Zobrazeno 1 - 10
of 166
pro vyhledávání: '"Tzu‑Fei Wang"'
Autor:
Stephanie Fontyn, Yuxin Bai, Samantha Bolger, Kaity Greco, Tzu-Fei Wang, Caroline Hamm, Andrea Cervi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-6 (2024)
Abstract Inferior vena cava (IVC) filters are considered when patients with venous thromboembolism (VTE) develop a contraindication to anticoagulation. Use of IVC filters is increasing, despite associated complications and lack of data on efficacy in
Externí odkaz:
https://doaj.org/article/3e8363cde77b415897fa05f71bc00a2c
Autor:
Rahman Ladak, Massimo Sementilli, Jillian Calandra, Alejandro Lazo-Langner, Deborah Siegal, Tzu-Fei Wang, Rong Luo, Andrea L. Cervi
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 6, Pp 102540- (2024)
Externí odkaz:
https://doaj.org/article/0a0445e0583c49afa90180a0458678e0
Autor:
Michelle Pradier, Tzu-Fei Wang, Deborah M. Siegal, Grégoire Le Gal, Marc Carrier, Aurélien Delluc
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/9ab2ceadfa834a7698f1a08051b7f906
Autor:
Kristen M. Sanfilippo, Tzu-Fei Wang
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 3, Iss s1 (2024)
Mortality and venous thromboembolism (VTE) are major risks for patients with hematological malignancies. However, they are commonly underrepresented in major clinical trials of VTE. Treatment decisions are further complicated by the unique characteri
Externí odkaz:
https://doaj.org/article/30f481a379d242dda85a8d0cadbc95b5
Autor:
Yishi Tan, Marc Carrier, Nicola Curry, Michael Desborough, Kathryn Musgrave, Marie Scully, Tzu-Fei Wang, Mari Thomas, Simon J. Stanworth
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 3, Iss s1 (2024)
Individuals who have thrombocytopenia and cancer-associated thrombosis (CAT) are difficult to manage because they have a high risk of bleeding and recurrent thrombosis. The International Society on Thrombosis and Haemostasis guidelines for the manage
Externí odkaz:
https://doaj.org/article/6f61d65acb31462687fe55d0a816c0e1
Autor:
Tzu-Fei Wang, Marc Carrier
Publikováno v:
Current Oncology, Vol 30, Iss 3, Pp 3032-3046 (2023)
Immune checkpoint inhibitors (ICIs) target programmed cell death (PD) 1 receptor and its ligand PD-L1, and have become an integral part of treatment regimens in many cancers including lung cancer, renal cell carcinoma, melanoma, and more. Cancer is a
Externí odkaz:
https://doaj.org/article/51560e84236346d59e9f44d7d131a3b4
Autor:
Kevin Hill, MD, Ewa Sucha, MSc, Emily Rhodes, MPH, Sarah Bota, MPH, Gregory L. Hundemer, MD, MPH, Edward G. Clark, MD, MSc, Mark Canney, MD, PhD, Ziv Harel, MD, MPH, Tzu-Fei Wang, MD, MSc, Marc Carrier, MD, MSc, Harindra C. Wijeysundera, MD, PhD, Greg Knoll, MD, MSc, Manish M. Sood, MD, MSc
Publikováno v:
CJC Open, Vol 4, Iss 3, Pp 315-323 (2022)
Background: Routinely used cardiac medications, based on pharmacokinetics, are hypothesized to increase drug levels of direct oral anticoagulants (DOACs), with the potential to increase the risk of hemorrhage. We set out to compare the risk for hemor
Externí odkaz:
https://doaj.org/article/7e70bc427666446bbfe336ef07bba9c0
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7601-7609 (2021)
Abstract Background Life dissatisfaction varies with different factors––particularly in the presence of chronic conditions, such as cancer. The combination of cancer and mental health disorders may increase life dissatisfaction due to lowered res
Externí odkaz:
https://doaj.org/article/53cbe66b5d1e4500988c1731b052f886
Autor:
Kristen M. Sanfilippo, Kenneth R. Carson, Tzu‐Fei Wang, Suhong Luo, Natasha Edwin, Nicole Kuderer, Jesse M. Keller, Brian F. Gage
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 1, Pp n/a-n/a (2022)
Abstract Background Guidelines recommend thromboprophylaxis for patients with multiple myeloma (MM) at high risk for venous thromboembolism (VTE). However, the optimal risk prediction model for VTE in MM remains unclear. Khorana et al developed a VTE
Externí odkaz:
https://doaj.org/article/113ae2b1ee5345e4ad565ab4976b3933
Autor:
Rick Ikesaka, Deborah Siegal, Ranjeeta Mallick, Tzu‐Fei Wang, Deborah Witham, Carolyn Webb, Marc Carrier, for the Canadian Venous Thromboembolism Research Network (CanVECTOR)
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 4, Pp n/a-n/a (2021)
Abstract Background Central venous catheter (CVC) insertion is an important risk factor for venous thromboembolism (VTE) among patients with cancer. Routine use of primary thromboprophylaxis in this patient population is not currently recommended. We
Externí odkaz:
https://doaj.org/article/e864d694b9554427b9b2ce59c0172700